Last reviewed · How we verify
Savolitinib Test Preparation
At a glance
| Generic name | Savolitinib Test Preparation |
|---|---|
| Also known as | HMPL-504, volitinib, AZD6094 |
| Sponsor | Hutchison Medipharma Limited |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Pharmacokinetic and Bioequivalence Study of Savolitinib Tablets in Healthy Chinese Male Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Savolitinib Test Preparation CI brief — competitive landscape report
- Savolitinib Test Preparation updates RSS · CI watch RSS
- Hutchison Medipharma Limited portfolio CI